QL ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
QL01 ANTINEOPLASTIC AGENTS
QL01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
QL01FF PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors
QL01FF09 tislelizumab
Last updated: 2024-01-17